[1]
“Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options”, Can Hematol Today, vol. 5, no. s01, pp. 2–9, Feb. 2026, doi: 10.58931/cht.2026.5s0181.